Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

71 results about "Forsythoside A" patented technology

Method for testing quality of antiviral oral liquid for treating hand-foot-and-mouth disease

The invention discloses a method for testing the quality of antiviral oral liquid for treating the hand-foot-and-mouth disease and relates to the technical field of medicaments. In the method for testing the quality, the quality is tested by using a high performance liquid chromatogram single-test multi-evaluation method. 10 ml of antiviral oral liquid contains no less than 60 mu g of (R,S)-goitrin, no less than 1 mg of forsythoside A, no less than 0.25 mg of forsythin and no less than 0.12 mg of forsythingenin. The method has the advantages that: the method is simple and convenient; the content of four active ingredients of the antiviral oral liquid can be tested at the same time; the quality of the antiviral oral liquid and the curative effect of the antiviral oral liquid on the hand-foot-and-mouth disease can be comprehensively evaluated by establishing a quantitative analysis result of the active ingredients of the antiviral oral liquid, so the antiviral oral liquid has a truly-controllable standard; and simultaneously, the medicinal material basis of a Chinese medicinal preparation, namely, the antiviral oral liquid in the aspect of curing the hand-foot-and-mouth disease is put forward in China for the first time.
Owner:GUANGZHOU XIANGXUE PHARMA CO LTD

Olive total phenylethanoid glycoside composition and preparation and application thereof

The invention discloses an olive total phenylethanoid glycoside composition. The olive total phenylethanoid glycoside composition comprises 6 types of particular phenylethanoid glycoside compositions which include cistanoside E, calcelarioside B, verbascoside, isoverbascoside, forsythoside B and alyssonoside and are varied from a general formula A. Pathological tests show that the olive total phenylethanoid glycoside composition in the general formula A has good anti-liver fibrosis and liver protection effects, can be used as an active ingredient of medicines for resisting liver diseases, canbe independently used or combined with proper excipients and the like, and is prepared into oral or non-oral dosage forms by conventional methods to be used for preparing medicines for treating liverdiseases.
Owner:HENAN UNIV OF SCI & TECH

Traditional Chinese medicine composition with effects of clearing away heat and toxic materials as well as preparation method and drug preparation thereof

The invention relates to a traditional Chinese medicine composition with effects of clearing away heat and toxic materials as well as preparation method and drug preparation thereof, and belongs to the field of traditional Chinese medicines. The traditional Chinese medicine composition with effects of clearing away heat and toxic materials comprises baicalin, chlorogenic acid, galuteolin, forsythiaside a, (R, S)-epigoitrin and total volatile oil, wherein a weight ratio of the baicalin to chlorogenic acid to galuteolin to forsythiaside a to (R, S)-epigoitrin to total volatile oil is (150-600):(10-60):(1-6):(10-50):(2-9):(50-200); and the total volatile oil is extracted from lonicera japonica, fructus forsythia and isatis root. The traditional Chinese medicine composition disclosed by the invention is high in content of active ingredients and excellent in curative effect of the product.
Owner:HEILONGJIANG ZBD PHARMA +1

Forsythoside A drug composite

The invention discloses a forsythoside A drug composite, which contains forsythoside A and oleaginous base plant extract, wherein, the mass ratio of forsythoside A to oleaginous base and / or oleaginous base plant extract is 0.05:10-0.5:10. The forsythoside A drug composite can be well absorbed in gastrointestinal tracts, can acquire higher blood concentration, and has high oral bioavailability.
Owner:SHANGHAI INST OF PHARMA IND

Application of forsythiaside A to preparation of anti-esophageal cancer medicine

ActiveCN113209113APromote apoptosisTo achieve the purpose of resisting esophageal squamous cell carcinomaOrganic active ingredientsAntineoplastic agentsMalignant phenotypeOncology
The invention provides an application of forsythiaside A to preparation of an anti-esophageal squamous cell carcinoma medicine. The forsythiaside A is used as an active component in the anti-esophageal squamous cell carcinoma medicine, and the molecular formula of the forsythiaside A is C29H36O15. The forsythoside A mainly inhibits proliferation, clone formation and cell migration of esophageal squamous carcinoma cells, or promotes apoptosis of the esophageal squamous carcinoma cells by retarding the cycle of the esophageal squamous carcinoma cells so as to achieve the purpose of resisting the esophageal squamous carcinoma. Therefore, the forsythiaside A has an inhibiting effect on the malignant phenotype of the esophageal squamous carcinoma.
Owner:ZHENGZHOU NORMAL UNIV

Method for determining contents of seven components in lonicera and forsythia powder by adopting dual-wavelength quantitative analysis of multi-components by single marker

The invention discloses a method for determining the contents of seven components in lonicera and forsythia powder by adopting dual-wavelength quantitative analysis of multi-components by a single marker, which comprises the following steps of: respectively taking neochlorogenic acid, chlorogenic acid, forsythiaside A, isochlorogenic acid A, isochlorogenic acid C, forsythin and arctiin as reference substances and forsythiaside A as an internal reference substance, calculating the relative correction factors of arctiin and forsythin at 237 nm, calculating the relative correction factors of neochlorogenic acid, chlorogenic acid, isochlorogenic acid A and isochlorogenic acid C at 327 nm, taking a forsythiaside A reference substance solution and a test solution, injecting the solutions into a high performance liquid chromatograph, and calculating the contents of seven components including forsythiaside A, forsythin, arctiin, neochlorogenic acid, chlorogenic acid, isochlorogenic acid A and isochlorogenic acid C in the lonicera and forsythia powder according to the relative correction factors. According to the invention, the same test solution is adopted to determine the contents of seven components under two absorption wavelengths, so that the detection efficiency is improved, and the detection cost is reduced.
Owner:SHANDONG ACAD OF CHINESE MEDICINE

Livestock and poultry feed additives and application thereof

The invention discloses livestock and poultry feed additives and application thereof. As for one of the feed additives, dried fructus forsythia fruits are taken as raw materials, a fructus forsythia extract is obtained through alcohol extraction, main active components in the fructus forsythia extract comprise phillygenin, phillyrin, forsythialan A and forsythoside A, and the other feed additive is 25-hydroxyl vitamin D3. According to two methods for improving reproductive performance of multiparous sows and improving breast milk components through the additives at the latter half of gestation, by using the fructus forsythia extract, the newborn litter weight of lactating sows can be increased significantly, the mortality rate of newborn piglets is decreased, and the content of milk fat and milk proteins in colostrums is increased; and by using the 25-hydroxyl vitamin D3, the average newborn piglet weight of the lactating sows can be increased significantly, and the content of the milkfat and the milk proteins in the colostrums is increased. Effective means are provided for improving the immunity function of the sows and effectively resisting stress caused by metabolic enhancementduring gestation, parturition and lactation, and thus the development of sow breeding industry is promoted.
Owner:CHINA AGRI UNIV

Establishhment method for fructus forsythiae medicine fingerprint

The invention belongs to the technical field of medicine analysis and specifically relates to an establishment method for a fructus forsythiae medicine fingerprint. The method specifically is realizedby the following steps of preparing a reference substance solution, taking appropriate amount of forsythin, forsythoside A, isoforsythiaside, rutin and forsythingenin reference substances, and preparing the reference substances into the reference substance solution; preparing a test sample solution, weighing fructus forsythiae medicine powder, carrying out heating reflux extraction, taking subsequent filtrate, carrying out filtering through utilization of filter membrane, taking the subsequent filtrate as a sample solution, measuring the sample solution and a puerarin water solution, and carrying out mixing uniformly to obtain the test sample solution; and carrying out detection through adoption of a high performance liquid chromatography and establishing the fingerprint. According to themethod, high performance liquid chromatography detection is carried out on the fructus forsythiae medicine through adoption of different gradient elution, a separation effect is good; through external addition of an internal standard, the established fingerprint has a semiquantitative function, so change of components among samples can be effectively expressed, and quality of the samples can be judged relatively precisely; and quality monitoring can be carried out on the raw material fructus forsythiae medicine relatively comprehensively.
Owner:SHANDONG ACAD OF CHINESE MEDICINE

Application of forsythia flower yellow pigment in preparing anti-oxidative stress injury drug

The invention provides an application of forsythia flower yellow pigment in preparing an anti-oxidative stress injury drug. The preparation step of the yellow pigment is as follows: adding dried forsythia flower powder into 95% ethanol according to a solid-liquid ratio of 1:100, performing water bath at 50 DEG C, and performing extraction by a hot reflux method; and performing suction filtration separation, repeating extraction twice, collecting the extractive liquid, performing rotary evaporation concentration, carrying out freeze drying, and collecting dry powder. The yellow pigment contains: rutin, forsythoside A, rosin, forsythin and the like. The yellow pigment can effectively eliminate ROS free radicals in caenorhabditis elegans body by up-regulating the expression of DAF-16 and SKN-1 target genes, increase the activity of antioxidant enzymes in elegans body, reduce the free radical content in the elegans body and weaken the oxidative stress damage in the elegans body by juglone,and can significantly prolong the lifespan of wild-type elegans N2 and daf-16 mutant elegans under oxidative stress, thereby increasing the resistance of elegans to oxidative stress. The yellow pigment can also be used in the preparation of functional foods resistant to oxidative stress damage.
Owner:SHANXI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products